Source-grounded facts extracted from MEDICAL PROPERTIES TRUST INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
MEDICAL PROPERTIES TRUST INC shareholders approved Approval of Medical Properties Trust, Inc. Second Amended and Restated 2019 Equity Incentive Plan at the 2026-05-28 meeting.
“Proposal 4: The approval of the Medical Properties Trust, Inc. Second Amended and Restated 2019 Equity Incentive Plan: For: Against: Abstensions: Broker Non-Votes: 280,147,111 60,763,845 5,385,218 122,390,383”
MEDICAL PROPERTIES TRUST INC shareholders approved Advisory vote on named executive officer compensation at the 2026-05-28 meeting.
“Proposal 3: The approval of a non-binding, advisory vote on named executive officer compensation: For: Against: Abstensions: Broker Non-Votes: 245,721,749 96,721,390 3,853,035 122,390,383”
MEDICAL PROPERTIES TRUST INC shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
“Proposal 2: The ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026: For: Against: Abstensions: Broker Non-Votes: 459,883,831 6,189,396 2,613,330 —”
MEDICAL PROPERTIES TRUST INC shareholders approved Election of nine directors at the 2026-05-28 meeting.
“Proposal 1: The election of nine directors to the board of directors of the Company, to serve until the next annual meeting of stockholders in 2027 or until their respective successors are elected and qualify: Nominee: For: Against: Abstensions: Broker Non-Votes: Edward K. Aldag, Jr. 326,606,762 14,394,945 5,294,467 122,390,383 G. Steven Dawson 327,763,006 14,290,105 4,243,063 122,390,383 R. Steven Hamner 323,486,576 18,502,877 4,306,721 122,390,383 Caterina A. Mozingo 329,917,176 12,147,873 4,231,125 122,390,383 Emily W. Murphy 324,431,895 17,629,502 4,234,777 122,390,383 Elizabeth N. Pitman 320,148,318 21,945,226 4,202,630 122,390,383 D. Paul Sparks, Jr. 313,040,588 28,974,759 4,280,827 122,390,383 Michael G. Stewart 326,486,132 15,528,913 4,281,129 122,390,383 C. Reynolds Thompson, III 319,263,889 22,700,542 4,331,743 122,390,383”
MEDICAL PROPERTIES TRUST INC reported first quarter ended March 31, 2026 results: net income Net income of $0.05.
“Net income of $0.05 and Normalized Funds from Operations (“NFFO”) of $0.14 for the 2026 first quarter, all on a per share basis;”
MEDICAL PROPERTIES TRUST INC received a nyse noncompliance notice notice regarding late filing (rules 802.01E).
“May 16, 2024, the Company received a notice (the “Notice”) from the New York Stock Exchange (“NYSE”) indicating that, due to the delay in filing of the Quarterly Report, the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, which requires timely filing of periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Notice has no immediate effect on the listing of the Company’s common stock on the NYSE. Under NYSE rules, the Company has six months from May 15, 2024 to regain compliance with NYSE listing standards by filing the Quarte”
MEDICAL PROPERTIES TRUST INC announced a impairment with charges of approximately $470 million of additional impairment charges affecting investments in Steward, including 9.9% equity interest and $362 million loan due from affiliates of Steward.
“the Company has concluded the investments in Steward have been further materially impaired and has recorded approximately $470 million of additional impairment charges in the quarter ended March 31, 2024 that fully reserves for the remaining value of our 9.9% equity interest in Steward and the $362 million loan due from affiliates of Steward, along with an accrual for property taxes and obligations not paid by Steward under its master leases.”
MEDICAL PROPERTIES TRUST INC reported first quarter ended March 31, 2024 results: net income ($736 million) (($1.23) per share), EPS ($1.23) per share.
“Net loss for the first quarter ended March 31, 2024 was ($736 million) (($1.23) per share) compared to net income of $33 million ($0.05 per share) in the year earlier period.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.